Janux Therapeutics, Inc. (JANX) Shareholder/Analyst Call Transcript

PresentationI would now like to turn the conference call over to Chad Rubin, Head of Investor Relations for Janux. You may begin your conference.Good afternoon. My name is Jeannie, and I will be your conference operator today. I would like to welcome you to the Janux Therapeutics Clinical Data Update Webcast. [Operator Instructions]Chad Rubin Thank you, Jeannie, and good afternoon, everyone. Today, Janux issued a press release announcing interim clinical data for the company's JANX007 clinical program. This ...